Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.

Journal: Cell

Published: 2020-03-05

DOI: 10.1016/j.cell.2020.02.035

Affiliations: 27

Authors: 41

Go to article
Institutions Share
Klinik für Neurologie, RUB, Germany 0.27
The Mina and Everard Goodman Faculty of Life Sciences, BIU, Israel 0.07
Institute of Biochemistry and Pathobiochemistry, RUB, Germany 0.06
Institute for Agricultural and Nutritional Sciences, MLU, Germany 0.05
Faculty of Medicine, UR, Germany 0.05
Experimental and Clinical Research Center (ECRC), Germany 0.05
Department of Medicine 3 - Rheumatology and Immunology, FAU, Germany 0.05
Clinical-Microbiomics A/S, Denmark 0.05
Institute of Neuropathology, Uni Freiburg, Germany 0.04
Institute for Nanotechnology and Advanced Materials (BINA), BIU, Israel 0.03
Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany 0.02
Faculty of Medicine, RUB, Germany 0.02
Katholisches Klinikum Bochum (KKB), RUB, Germany 0.02
Faculty of Biology and Biotechnology, RUB, Germany 0.02
Berlin Institute for Medical Systems Biology (BIMSB), MDC, Germany 0.02
Cardiovascular and Metabolic Disease, MDC, Germany 0.02
University Hospital Duesseldorf (UKD), Germany 0.02
Biological and Medical Research Center (BMFZ), HHU, Germany 0.02
Evangelisches Krankenhaus Düsseldorf (EVK), Germany 0.02
Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. (ISAS), Germany 0.01
UCLA Department of Integrative Biology and Physiology (IBP), United States of America (USA) 0.01
UCLA Brain Research Institute (BRI), United States of America (USA) 0.01
Faculty of Medicine, Uni Freiburg, Germany 0.01
Cluster of Excellence - Centre for Integrative Biological Signalling Studies (CIBSS), Uni Freiburg, Germany 0.01
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0.01
Center for Basics in NeuroModulation (NeuroModulBasics), Uni Freiburg, Germany 0.01